Nano Letters · 2021 · 24 citations · 29 references
MedicineGeneticsMolecular BiologyCancer GeneticsMolecular DiagnosticsMolecular OncologyAtomic Force MicroscopyCancer Molecular DiagnosticsCirculating Tumor Dna AnalysisMutation AnalysisCirculating Cell-free Dna AnalysisCirculating Tumor Dna DetectionCirculating Tumor Dna TestingDirect DetectionGenetic Mutation DetectionPcr-based DetectionSensitivityTumor Mutation Detection
Cell-free DNA (cfDNA) analysis, specifically circulating tumor DNA (ctDNA) analysis, provides enormous opportunities for noninvasive early assessment of cancers. To date, PCR-based methods have led this field. However, the limited sensitivity/specificity of PCR-based methods necessitates the search for new methods. Here, we describe a direct approach to detect KRAS G12D mutated genes in clinical ctDNA samples with the utmost LOD and sensitivity/specificity. In this study, MutS protein was immobilized on the tip of an atomic force microscope (AFM), and the protein sensed the mismatched sites of the duplex formed between the capture probe on the surface and mutated DNA. A noteworthy LOD (3 copies, 0.006% allele frequency) was achieved, along with superb sensitivity/specificity (100%/100%). These observations demonstrate that force-based AFM, in combination with the protein found in nature and properly designed capture probes/blockers, represents an exciting new avenue for ctDNA analysis.
29
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
Sandra Misale, Rona Yaeger, Sebastijan Hobor et al. · Nature · 2012 · 1.9K citations · Full text
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
Muhammed Murtaza, Sarah‐Jane Dawson, Dana W.Y. Tsui et al. · Nature · 2013 · 1.6K citations